|
Most practitioners of neuroanesthesia believe that a premium should be placed on "smooth" emergence, that is, one free of coughing/straining and arterial hypertension. Avoidance of arterial hypertension is seen as desirable because of the belief that arterial hypertension can contribute to intracranial bleeding and increased edema formation.[166] [167] [168] [169] In the face of a poorly autoregulating cerebral vasculature, hypertension also has the potential, through vascular engorgement, to contribute to elevation of ICP. Much of the concern with coughing/straining has a similar basis. The sudden increases in intrathoracic pressure are transmitted to both arteries and veins, and the transient increases produced in both cerebral arterial and venous pressure have the same potential consequences: edema formation, bleeding, and elevation of ICP. Coughing is a specific concern with certain individual procedures. In the circumstances of transsphenoidal pituitary surgery
It should be acknowledged that there is a paucity of systematically obtained clinical data to give a perspective to the actual magnitude of the risks associated with an emergence that is not "smooth." One clinical investigation confirmed the association of increased CBF velocity and hypertension occurring during emergence. [170] A second retrospective study revealed that elevated postoperative blood pressure was a correlate of intracerebral bleeding after craniotomy.[171] However, there is in fact no proof to show that it is specifically hypertension occurring at emergence that is correlated with postoperative intracerebral bleeding. The same acknowledgment must be made with the matter of edema formation. It has been demonstrated in anesthetized animals that sudden substantial increases in arterial pressure can result in breech of the blood-brain barrier with extravasation of tracers such as Evan's blue.[167] However, no data have confirmed that the hypertensive pressure transients associated with the typical coughing episode or with emergence are in fact associated with increased edema formation. Nonetheless, it seems reasonable to take measures, to the extent that these measures do not themselves add potential patient morbidity, to prevent these occurrences.
A common method for the management of systemic hypertension during the last stages of a craniotomy is the expectant or reactive administration (or both) of vasoactive drugs, most commonly labetalol and esmolol.[172] Other drugs, including enalapril and diltiazem, have been used to good effect. Administration of dexmedetomidine during the procedure and up to 30 to 60 minutes before conclusion of the procedure has also been reported to lessen the requirement for antihypertensives during emergence.[173] There are also many approaches to the prevention of coughing and straining. We have several biases, however. We encourage trainees to include in their anesthetic technique "as much narcotic as is consistent with spontaneous ventilation at the conclusion of the procedure." That practice is based on the same physiologic effect that justifies the administration of codeine and related compounds as antitussive medication, specifically, the depression of airway reflexes by narcotics. We also have the bias that patients emerge more rapidly and smoothly when the last inhaled anesthetic to be withdrawn is nitrous oxide and that clinicians should seek to avoid the "neither here nor there" phase of anesthesia that occurs in patients who are stimulated in the face of residual exhaled concentrations of volatile anesthetic on the order of 0.2 to 0.3 MAC. A common practice among neuroanesthetists near the conclusion of a craniotomy is the relatively early discontinuation of the volatile anesthetic and supplementation of residual nitrous oxide with propofol by either bolus increments or infusion at rates in the range of 25 to 100 µg/kg/min.
An additional principle relevant to emergence from neurosurgical procedures that practitioners will learn either from a book or by bad experience is that emergence should be timed to coincide, not with the final suture, but rather with the conclusion of the application of the head dressing. Many a good anesthetic for neurosurgery has been spoiled by severe coughing and straining that occur in association with endotracheal tube motion during application of the head dressing. Another nuance of our practice has been to withhold the administration of neuromuscular antagonists as long as possible as a hedge against misjudgment while lightening anesthesia in a patient in the later stages of the procedure. An additional popular and apparently effective technique for reducing airway responsiveness and the likelihood of coughing/straining while reducing the depth of anesthesia is the administration of lidocaine. Bolus doses on the order of 1.5 mg/kg, often given as application of the head dressing begins, are appropriate for this purpose.
The premium placed on minimizing coughing/straining and hypertension will result, in most instances, in patients being extubated very expediently once extubation is appropriate. In some instances, one may be tempted to extubate patients before complete recovery of consciousness. This practice may be acceptable in some circumstances. However, it should be undertaken with caution when the circumstances of the surgical procedure make it possible that neurologic events may have occurred that will delay recovery of consciousness or when lower cranial nerve dysfunction may be present. In these circumstances, it will generally be best to wait until the likelihood of the patient's recovery of consciousness is confirmed or until patient cooperation and airway reflexes are likely to have recovered (or until both).
|